Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
This is a critical situation demanding immediate, decisive, and ethical action. Patient safety and regulatory integrity must precede financial preservation. Delaying disclosure is legally and ethically indefensible, particularly given the severity of the side effect (liver failure).Read the full answer
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer